TPG RE Finance Trust approves new $25 million share repurchase program

Published 04/09/2025, 21:22
TPG RE Finance Trust approves new $25 million share repurchase program

NEW YORK - TPG RE Finance Trust, Inc. (NYSE:TRTX) announced Thursday that its board of directors has approved a new share repurchase program authorizing the company to buy back up to $25 million of its common stock. According to InvestingPro data, the company’s stock has shown strong returns over the past three months, though price movements remain volatile. Analysis suggests the stock is currently trading below its Fair Value.

The program allows for repurchases on the open market or through privately negotiated transactions, including under 10b5-1 plans. This initiative replaces a previous $25 million authorization that was fully utilized during the third quarter of 2025.

TPG RE Finance Trust is a commercial real estate finance company that focuses on originating, acquiring, and managing primarily first mortgage loans secured by institutional properties in primary and select secondary markets across the United States.

The company is externally managed by TPG RE Finance Trust Management, L.P., which is part of TPG Real Estate, the real estate investment platform of global alternative asset management firm TPG Inc. (NASDAQ:TPG).

The announcement was made in a press release statement issued by the company. No specific timeline was provided for the implementation or completion of the new share repurchase program.

In other recent news, TPG Inc. reported a robust financial performance for the second quarter of 2025, with earnings per share reaching $0.69, significantly surpassing the analyst forecast of $0.44. This marks a 56.82% surprise increase. The company’s revenue also nearly doubled expectations, coming in at $920.54 million against the anticipated $460.7 million. TPG declared a record quarterly dividend of $0.59 per share, reflecting a 40% increase from the previous year. In addition to its financial achievements, TPG, along with the Qatar Investment Authority, proposed a $1.4 billion buyout of Kangji Medical Holdings Ltd., offering HK$9.25 per share. Furthermore, TPG announced the pricing of $500 million in senior notes due in 2036, with an interest rate of 5.375%. These notes are intended to repay existing debt and are guaranteed by TPG and certain subsidiaries. Analyst firm Citizens JMP reiterated a Market Perform rating for TPG following these developments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.